#Notallbreastcanceristhesame

Is the #OncotypeDX recurrence score (RS) the best measure for #lobular #breastcancer? This retrospective analysis in @ACS_Research Journals suggests NO. 1/6 #bcsm @oncoalert @practiceupdate @medscape @elbcc @oesterreich @metzger https://acs
Read more